Remedent, Inc. (REMI)
OTCMKTS · Delayed Price · Currency is USD
0.0006
+0.0001 (20.00%)
At close: Dec 19, 2025
Remedent Revenue
In the fiscal year ending March 31, 2023, Remedent had annual revenue of 46.11K EUR, down -88.53%. Remedent had revenue of -459.56K in the quarter ending March 31, 2021.
Revenue
46.11K EUR
Revenue Growth
-94.86%
P/S Ratio
0.23
Revenue / Employee
15.37K EUR
Employees
3
Market Cap
11.56K USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2023 | 46.11K | -355.79K | -88.53% |
| Mar 31, 2022 | 401.91K | 112.97K | 39.10% |
| Mar 31, 2021 | 288.94K | 68.77K | 31.23% |
| Mar 31, 2020 | 220.17K | -1.21M | -84.59% |
| Mar 31, 2019 | 1.43M | -762.54K | -34.80% |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| InnerScope Hearing Technologies | 14.51M |
| Medite Cancer Diagnostics | 8.13M |
| Lancer Orthodontics | 6.19M |
| SheerVision | 2.84M |
| American Scientific Resources | 1.05M |
| Paradigm Medical Industries | 757.00K |
| Wearable Health Solutions | 600.26K |
| Medical International Technology | 397.69K |
Remedent News
- 4 years ago - Remedent, Inc. Files Form 15 to Suspend SEC Exchange Act Registration and Applies to Qualify for OTC Markets Alternative Reporting Standard for Pink Sheet Companies - GlobeNewsWire